| List Name |
Annotation |
Enrichment |
p-value |
| regulation of transcription, DNA-dependent |
AmiGO Browser |
1.93 |
2.19e-03 |
| regulation of transcription |
AmiGO Browser |
1.87 |
2.75e-03 |
| negative regulation of transcription factor activity |
AmiGO Browser |
23.80 |
3.16e-03 |
| transcription, DNA-dependent |
AmiGO Browser |
1.88 |
3.20e-03 |
| regulation of metabolic process |
AmiGO Browser |
1.78 |
3.23e-03 |
| RNA biosynthetic process |
AmiGO Browser |
1.87 |
3.25e-03 |
| regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
1.80 |
4.32e-03 |
| transcription |
AmiGO Browser |
1.79 |
4.79e-03 |
| regulation of cellular process |
AmiGO Browser |
1.56 |
5.09e-03 |
| regulation of cellular metabolic process |
AmiGO Browser |
1.73 |
6.23e-03 |
| regulation of biological process |
AmiGO Browser |
1.51 |
7.17e-03 |
| RNA metabolic process |
AmiGO Browser |
1.67 |
8.09e-03 |
| biological regulation |
AmiGO Browser |
1.46 |
0.01 |
| anterior/posterior pattern formation |
AmiGO Browser |
6.13 |
0.01 |
| folic acid and derivative biosynthetic process |
AmiGO Browser |
40.45 |
0.02 |
| regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
2.31 |
0.03 |
| drug transport |
AmiGO Browser |
33.71 |
0.03 |
| striated muscle development |
AmiGO Browser |
4.43 |
0.03 |
| forebrain development |
AmiGO Browser |
7.22 |
0.03 |
| interferon type I production |
AmiGO Browser |
28.90 |
0.03 |
| fear response |
AmiGO Browser |
28.90 |
0.03 |
| interferon type I biosynthetic process |
AmiGO Browser |
28.90 |
0.03 |
| blood vessel morphogenesis |
AmiGO Browser |
3.26 |
0.04 |
| cell motility |
AmiGO Browser |
2.28 |
0.04 |
| localization of cell |
AmiGO Browser |
2.28 |
0.04 |
| blood vessel remodeling |
AmiGO Browser |
25.28 |
0.04 |
| positive regulation of actin filament polymerization |
AmiGO Browser |
25.28 |
0.04 |
| regulation of transcription factor activity |
AmiGO Browser |
6.42 |
0.04 |
| regionalization |
AmiGO Browser |
3.97 |
0.04 |
| neuron migration |
AmiGO Browser |
5.95 |
0.04 |
| regulation of receptor mediated endocytosis |
AmiGO Browser |
20.23 |
0.05 |
| paraxial mesoderm development |
AmiGO Browser |
20.23 |
0.05 |
| camera-type eye development |
AmiGO Browser |
18.39 |
0.05 |
| folic acid and derivative metabolic process |
AmiGO Browser |
18.39 |
0.05 |
| blood vessel development |
AmiGO Browser |
2.86 |
0.05 |
| regulation of caspase activity |
AmiGO Browser |
5.39 |
0.05 |
| vasculature development |
AmiGO Browser |
2.81 |
0.06 |
| negative regulation of transcription, DNA-dependent |
AmiGO Browser |
2.77 |
0.06 |
| collagen fibril organization |
AmiGO Browser |
15.56 |
0.06 |
| mesoderm development |
AmiGO Browser |
4.93 |
0.06 |
| transcription from RNA polymerase II promoter |
AmiGO Browser |
1.83 |
0.06 |
| brain development |
AmiGO Browser |
3.32 |
0.06 |
| chromatin remodeling |
AmiGO Browser |
4.82 |
0.07 |
| skeletal muscle development |
AmiGO Browser |
4.76 |
0.07 |
| positive regulation of protein import into nucleus |
AmiGO Browser |
14.45 |
0.07 |
| negative regulation of caspase activity |
AmiGO Browser |
14.45 |
0.07 |
| positive regulation of protein transport |
AmiGO Browser |
14.45 |
0.07 |
| positive regulation of transcription factor import into nucleus |
AmiGO Browser |
14.45 |
0.07 |
| germ cell migration |
AmiGO Browser |
14.45 |
0.07 |
| negative regulation of cellular process |
AmiGO Browser |
1.60 |
0.07 |
| heterochromatin formation |
AmiGO Browser |
13.48 |
0.07 |
| chromatin silencing |
AmiGO Browser |
13.48 |
0.07 |
| protein folding |
AmiGO Browser |
2.54 |
0.08 |
| positive regulation of nucleocytoplasmic transport |
AmiGO Browser |
12.64 |
0.08 |
| L-fucose catabolic process |
AmiGO Browser |
11.90 |
0.08 |
| fucose catabolic process |
AmiGO Browser |
11.90 |
0.08 |
| memory |
AmiGO Browser |
11.90 |
0.08 |
| negative regulation of biological process |
AmiGO Browser |
1.55 |
0.08 |
| regulation of actin filament polymerization |
AmiGO Browser |
11.24 |
0.09 |
| negative regulation of progression through mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
| actin polymerization and/or depolymerization |
AmiGO Browser |
4.09 |
0.09 |
| actin filament-based process |
AmiGO Browser |
2.39 |
0.09 |
| negative regulation of gene expression, epigenetic |
AmiGO Browser |
10.65 |
0.09 |
| fructose metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| ER-nuclear signaling pathway |
AmiGO Browser |
10.11 |
0.09 |
| protein targeting to ER |
AmiGO Browser |
10.11 |
0.09 |
| cotranslational protein targeting to membrane |
AmiGO Browser |
10.11 |
0.09 |
| pattern specification process |
AmiGO Browser |
2.78 |
0.09 |
| nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
1.31 |
0.10 |
| vesicle targeting |
AmiGO Browser |
9.63 |
0.10 |
| L-fucose metabolic process |
AmiGO Browser |
9.63 |
0.10 |
| plasma membrane organization and biogenesis |
AmiGO Browser |
9.63 |
0.10 |
| one-carbon compound metabolic process |
AmiGO Browser |
3.75 |
0.10 |
| release of cytochrome c from mitochondria |
AmiGO Browser |
9.19 |
0.10 |
| cell structure disassembly during apoptosis |
AmiGO Browser |
9.19 |
0.10 |
L2L Microarray Analysis Tool